NewGenIvf Says Granted Request For Continued Listing On Nasdaq

(RTTNews) - NewGenIvf Group Limited (NIVF), a fertility services provider, Thursday said the Nasdaq Hearings Panel has granted its request to continue listing on the Nasdaq Stock Market.

The company said it has already made a reverse stock split on February 11, 2025 to achieve compliance with the shareholders' equity minimum for listing on the Nasdaq Capital Market.

Additionally, NewGenIvf has appointed Thorain Ko as Business Development Director, who has more than 30 years of experience in business development, healthcare, and direct-selling. Most recently, he was the Sales and Marketing Director at USANA Health Sciences.